Markets › Stocks › BRAWN
BR

Brawn Biotech Ltd

NSE: BRAWNBSE: 530207Healthcare
₹21.05
▲ +0.00%
NSE · 15-min delayed
Mkt Cap
₹6 Cr
P / E
15.8
P / B
1.4
ROE
-3.2%
52W High
₹24.37
52W Low
₹16.15
Key Metrics
Market Cap
₹6 Cr
P / E
15.8
P / B
1.4
ROCE
-2.5%
ROE
-3.2%
Div Yield
-
Revenue · ₹ Cr
50
FY20
35
FY21
9
FY22
22
FY23
16
FY24
13
FY25
17
FY26
Net Profit · ₹ Cr
1
FY20
-1
FY21
-2
FY22
-1
FY23
-2
FY24
-2
FY25
1
FY26
EPS · ₹ per share
₹4.6
FY19
₹2.0
FY20
₹-1.6
FY21
₹-5.3
FY22
₹-3.0
FY23
₹-5.1
FY24
₹3.3
FY26
Q4 2025 snapshot
Sales
₹4 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.17
Scorecard · 7 axes
Quality
Weak
33/100
Valuation
Good
15.8×
Growth
Bad
-15.3%
Profitability
Bad
-2.9%
Performance
Avg
+22.4%
Entry Point
Avg
86%
Red Flags
Strong
0 flags
Shareholding Pattern
52.9%Promoter
Promoter52.9%
DII0.3%
Public46.7%
Quarterly Results · ₹ Cr
QuarterFY24 09QFY24 12QFY25 03QFY25 06QFY25 09QFY25 12Q
Revenue3.33.852.355.894.984.4
Net Profit-0.344-0.432-0.4940.2360.0710.05
NPM %-10.4%-11.2%-21.0%4.0%1.4%1.1%
AlertPre-trade